Abbott Laboratories (ABT): Are Hedge Funds Right About This Stock?

Page 1 of 2

Abbott Laboratories (NYSE:ABT) was in 50 hedge funds’ portfolio at the end of December. ABT investors should be aware of a decrease in support from the world’s most elite money managers lately. There were 54 hedge funds in our database with ABT positions at the end of the previous quarter. An important piece of news came in this morning saying that Abbott Laboratories (NYSE:ABT) got a new Neutral rank at Credit Suisse.

FIX Hedge Funds Are Crazy About Abbott Laboratories (NYSE:ABT)

In the eyes of most traders, hedge funds are viewed as underperforming, old financial tools of years past. While there are greater than 8000 funds with their doors open at present, we at Insider Monkey choose to focus on the moguls of this club, about 450 funds. It is estimated that this group has its hands on the majority of the hedge fund industry’s total capital, and by keeping an eye on their best investments, we have found a few investment strategies that have historically outperformed the S&P 500 index. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points annually for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have topped the S&P 500 index by 24 percentage points in 7 months (explore the details and some picks here).

Equally as integral, positive insider trading sentiment is another way to parse down the stock market universe. As the old adage goes: there are many incentives for an executive to cut shares of his or her company, but only one, very simple reason why they would initiate a purchase. Several academic studies have demonstrated the impressive potential of this tactic if shareholders understand what to do (learn more here).

With these “truths” under our belt, we’re going to take a gander at the latest action surrounding Abbott Laboratories (NYSE:ABT).

What have hedge funds been doing with Abbott Laboratories (NYSE:ABT)?

At the end of the fourth quarter, a total of 50 of the hedge funds we track were bullish in this stock, a change of -7% from the previous quarter. With the smart money’s sentiment swirling, there exists a select group of noteworthy hedge fund managers who were boosting their stakes considerably.

According to our comprehensive database, Southeastern Asset Management, managed by Mason Hawkins, holds the most valuable position in Abbott Laboratories (NYSE:ABT). Southeastern Asset Management has a $455.5 million position in the stock, comprising 2% of its 13F portfolio. On Southeastern Asset Management’s heels is Southeastern Asset Management, managed by Mason Hawkins, which held a $244.9 million position; the fund has 1.1% of its 13F portfolio invested in the stock. Some other peers that hold long positions include Ric Dillon’s Diamond Hill Capital, Cliff Asness’s AQR Capital Management and Phill Gross and Robert Atchinson’s Adage Capital Management.

Seeing as Abbott Laboratories (NYSE:ABT) has witnessed bearish sentiment from the smart money, it’s safe to say that there lies a certain “tier” of hedge funds that decided to sell off their positions entirely in Q4. Intriguingly, Ricky Sandler’s Eminence Capital dropped the largest stake of the “upper crust” of funds we watch, comprising an estimated $81.3 million in stock., and Christopher Medlock James of Partner Fund Management was right behind this move, as the fund sold off about $61.3 million worth. These bearish behaviors are intriguing to say the least, as aggregate hedge fund interest fell by 4 funds in Q4.

How are insiders trading Abbott Laboratories (NYSE:ABT)?

Insider trading activity, especially when it’s bullish, is best served when the company in focus has experienced transactions within the past half-year. Over the latest half-year time period, Abbott Laboratories (NYSE:ABT) has seen 1 unique insiders purchasing, and 11 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Abbott Laboratories (NYSE:ABT). These stocks are St. Jude Medical, Inc. (NYSE:STJ), Zimmer Holdings, Inc. (NYSE:ZMH), Intuitive Surgical, Inc. (NASDAQ:ISRG), Stryker Corporation (NYSE:SYK), and Medtronic, Inc. (NYSE:MDT). This group of stocks belong to the medical appliances & equipment industry and their market caps are closest to ABT’s market cap.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!